Fabienne McClanahan,1,2 *John Gribben1
1. Barts Cancer Institute, Centre for Haemato-Oncology, Queen Mary University of London, London, UK
2. German Cancer Research Center (DKFZ), Heidelberg, Germany
*Correspondence to email@example.com
Disclosure: Fabienne McClanahan has no financial disclosures, and John Gribben is receiving Celgene Research Funding, Pharmacyclics Honoraria, and Roche Honoraria.
Support: The authors would like to thank Dr Caroline Charles for medical writing assistance with this manuscript.
Received: 22.05.14 Accepted: 16.06.14
Citation: EMJ Hema. 2014;1:70-79.
Read in EMJ Hematology 2014 – http://viewer.zmags.com/publication/3d823163#/3d823163/71
Also available for download – http://emjreviews.com/therapeutic-area/hematology/overcoming-immunodeficiency-chronic-lymphocytic-leukaemia-current-knowledge-perspectives/
Year of Production: